Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
Clinical trial NCT00267358 · COMPLETED
Trial details
- NCT number
- NCT00267358
- Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2006-10-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.